top of page
cbrc2025_2000x500.jpg

Running for Cure

​

Nirit Yarom, Shamir Medical Center

​

Colon cancer is the third most common cancer and second leading cause of cancer-related death worldwide. Standard management of stage III or high-risk stage II colon cancer includes surgery followed by 3 to 6 months of 5 Fluorouracil based chemotherapy w/wo oxaliplatin).
Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence is lacking. 
METHODS We participated in a phase 3, randomized trial conducted at 55 centers, patients with resected colon cancer who had completed adjuvant chemotherapy were assigned to participate in a structured exercise program (exercise group) or to receive health-education materials alone (health-education group) over a 3-year period. The primary end point was disease-free survival. 
RESULTS From 2009 through 2024, a total of 889 patients underwent randomization to the exercise group (445 patients) or the health-education group (444 patients). 
At a median follow-up of 7.9 years, disease-free survival was significantly longer in the exercise group than in the health-education group (hazard ratio for disease recurrence, new primary cancer, or death, 0.72; 95% confidence interval [CI], 0.55 to 0.94; P=0.02). The 5-year disease-free survival was 80.3% in the exercise group and 73.9% in the health-education group (difference, 6.4 percentage points; 95% CI, 0.6 to 12.2). Results support longer overall survival in the exercise group than in the health-education group (hazard ratio for death, 0.63; 95% CI, 0.43 to 0.94). The 8-year overall survival was 90.3% in the exercise group and 83.2% in the health education group (difference, 7.1 percentage points; 95% CI, 1.8 to 12.3). Musculoskeletal adverse events occurred more often in the exercise group than in the health-education group (in 18.5% vs. 11.5% of patients). 
CONCLUSIONS A 3-year structured exercise program initiated soon after adjuvant chemotherapy for colon cancer resulted in significantly longer disease-free survival and findings consistent with longer overall survival.

bottom of page